Cavidi
Cavidi at a glance
Cavidi is a company developing assays and an automated instrument for HIV viral load monitoring. The Ziva™ system, targeting district hospitals and regional laboratories (the mid-market segment) in the African market, is built on the comany’s long-standing chemistry solution used in its manual testing product
Cavidi facts
Sector
MedTech
Impilo entry date
February 2018
Impilo exit date
2020
HQ
Uppsala, Sweden
Impilo team
Fredrik Strömholm
Martin Fagerlund
Acquirer
Acquired by the original founders
Investment thesis
- Large unmet market need for suitable technology for viral load (VL) monitoring in the mid-segment in Africa; a segment currently not the focus of Cavidi’s competitors and that the Ziva™ solution is tailored for
- Big and rapidly growing market; The African HIV viral load market in Africa is c. USD 130m and growing 15%+
- Global funding expected to drive adoption of VL technology; a priority for WHO/other global organizations
UN SDG Goals
Other portfolio companies
Avia Pharma
Avia is a leading North European OTC/Rx platform
Read More
Stille
Stille is a well-established pioneer in the development of premium surgical instruments and advanced surgical tables
Read More
Decon
Decon develops, assembles, and distributes high-quality, power-assisted electrical solutions for wheelchairs
Read More